Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

OBJECTIVE: To assess the safety and efficacy of etoricoxib, a selective cyclo-oxygenase-2 inhibitor, in comparison with indometacin in the treatment of acute gouty arthritis. DESIGN: Randomised, double blind, active comparator controlled trial. SETTING: 43 outpatient study centres in 11 countries. P...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	BMJ
Egile Nagusiak:	Schumacher, H Ralph, Boice, Judith A, Daikh, David I, Mukhopadhyay, Saurabh, Malmstrom, Kerstin, Ng, Jennifer, Tate, Guillermo A, Molina, Javier
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMJ Publishing Group 2002
Gaiak:	Papers
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC116444/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12077033/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.324.7352.1488
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!